US -based pharmaceutical giant Eli Lilly recently launched its weight loss drug Mounjaro in India. Tirzepatide is the generic ...

We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an “important” weight loss treatment.

Lexicon's LX9851 targets ACSL5, a liver enzyme involved in fat metabolism that helps moderate fat accumulation and slow down ...

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

Body weight loss was associated with increased odds of type 2 diabetes remission in a dose-dependent manner among patients with obesity.

A new medical database automatically compiles the medical records of obese patients and those suffering from obesity-related diseases in a uniquely comprehensive and reliable manner.

The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

Since 2014, the Mexican government has taken steps to address the overweight and obesity epidemic. That year, it launched ...